Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer

Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Study ID
NCT02764268
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 70 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

Apatinib dose titration in Advanced or Metastatic Gastric Cancer

Key Dates

Start date
Nov 2, 2016
Status verified
Apr 2016
Primary completion
Dec 10, 2018
Completion
Apr 15, 2019

Study Design

Enrollment
60 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Apatinib

Primary Outcome Measure

Number of Participants With Dose Interruptions [ Time Frame: 15 months ]

Related Studies